Radu Tanasescu Selected Research

Radu Tanasescu Research Topics

Disease

21	Multiple Sclerosis 04/2024 - 06/2004
5	Epstein-Barr Virus Infections 03/2024 - 01/2018
5	Infections 03/2023 - 08/2010
4	Pain (Aches) 10/2023 - 04/2011
4	Inflammation (Inflammations) 01/2023 - 08/2010
3	Relapsing-Remitting Multiple Sclerosis 12/2023 - 01/2013
2	Chronic Pain 10/2023 - 04/2011
2	Optic Neuritis (Retrobulbar Neuritis) 01/2023 - 02/2020
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 02/2020
1	Knee Osteoarthritis 10/2023
1	Transverse Myelitis (Necrotizing Myelitis) 01/2023
1	Central Nervous System Diseases (CNS Diseases) 01/2023
1	Neuromyelitis Optica (Devic's Disease) 01/2023
1	Necrosis 10/2022
1	Neurogenic Inflammation 10/2022
1	Paresthesia (Dysesthesia) 01/2021
1	Enterovirus Infections 01/2021
1	Guillain-Barre Syndrome 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 02/2020
1	Myelitis 02/2020
1	Chronic Progressive Multiple Sclerosis 02/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018
1	HIV Infections (HIV Infection) 01/2018
1	Acute-Phase Reaction 01/2018
1	Chickenpox 12/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2015
1	Atrophy 04/2014
1	Lower Urinary Tract Symptoms 01/2014
1	Neuralgia (Stump Neuralgia) 09/2013
1	Cancer Pain 09/2013
1	Vomiting 04/2011
1	Chronic Disease (Chronic Diseases) 04/2011
1	Immune System Diseases (Immune Disorders) 08/2010
1	Neuroinflammatory Diseases 08/2010
1	Neurologic Manifestations (Neurological Manifestations) 07/2008

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 03/2023 - 01/2022
3	Sphingosine-1-Phosphate ReceptorsIBA 03/2023 - 04/2014
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2020 - 08/2015
3	Immunoglobulin G (IgG)IBA 02/2020 - 12/2017
3	CytokinesIBA 01/2018 - 08/2010
3	CannabinoidsIBA 09/2013 - 08/2010
2	Monoclonal AntibodiesIBA 12/2023 - 08/2015
2	Natalizumab (Tysabri)FDA Link 12/2023 - 10/2023
2	Analgesics (Analgesic Drugs)IBA 10/2023 - 09/2013
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 02/2020
2	NeuropeptidesIBA 10/2022 - 09/2015
2	Substance PIBA 10/2022 - 09/2015
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2013
2	Toll-Like Receptor 2IBA 01/2018 - 01/2017
2	Fingolimod Hydrochloride (FTY720)FDA Link 04/2014 - 01/2013
2	EndocannabinoidsIBA 09/2013 - 08/2010
2	nabiximols (Sativex)IBA 09/2013 - 04/2011
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 04/2024
1	ocrelizumabIBA 03/2024
1	IntegrinsIBA 12/2023
1	nitazoxanide (NTZ)FDA Link 12/2023
1	salicylhydroxamic acid (SHAM)IBA 10/2023
1	BNT162 VaccineIBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022
1	COVID-19 VaccinesIBA 01/2021
1	AnthelminticsIBA 01/2021
1	Interleukin-2 (IL2)IBA 07/2020
1	AntibodiesIBA 02/2020
1	EBV-encoded nuclear antigen 1IBA 01/2020
1	siponimodIBA 02/2019
1	C-Reactive ProteinIBA 01/2018
1	Viral ProteinsIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	InterferonsIBA 01/2018
1	Interleukin-12 (IL 12)IBA 09/2015
1	OtilimabIBA 08/2015
1	SphingosineIBA 04/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014
1	SteroidsIBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Growth Hormone (Somatotropin)IBA 03/2013
1	Clonidine (ST 155)FDA LinkGeneric 03/2013
1	teriflunomideIBA 01/2013
1	LigandsIBA 08/2010
1	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2004

Therapy/Procedure

7	Therapeutics 01/2021 - 07/2008
1	Transcranial Magnetic Stimulation 10/2023
1	Art Therapy 01/2018
1	Catheters 01/2014